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Background: Warfarin is the most commonly prescribed oral anticoagulant for the prevention
and treatment of venous thromboembolism. Due to its narrow therapeutic index, warfarin requires
close monitoring of the international normalized ratio (INR) to ensure proper anticoagulation
control and safety. INRs outside of this range are strongly associated with an increased risk of
major bleeding, thromboembolic events, and death. Patient self-testing (PST) using a point-ofcare device allows patients to monitor INR results at home. Evidence shows that PST improves
the clinical outcomes of warfarin therapy compared to usual care, which includes laboratory INR
monitoring. Purpose: To compare the clinical effectiveness of INR patient self-testing in adults
on warfarin therapy versus usual care in an internal medicine practice. Conclusions: On average,
PST achieved tighter anticoagulation control compared to usual care. PST provided more
consistent and less variable INR results within the therapeutic range. These findings are clinically
and statistically significant, suggesting the clinical efficacy of PST. Clinical Implications: These
outcomes warrant the comparison of different INR meters, in terms of patient choice and
satisfaction.
KEY WORDS: INR, warfarin, anticoagulation, patient self-testing, home monitoring, point-ofcare device
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Background
Warfarin is the most commonly prescribed oral anticoagulant for the prevention and
treatment of venous thromboembolism associated with chronic atrial fibrillation and mechanical
heart valves [1]. Due to its narrow therapeutic index, warfarin requires regular monitoring of the
international normalized ratio (INR) to ensure proper anticoagulation control [2]. The INR
therapeutic range for anticoagulation therapy is between 2.0 and 3.0, except for mechanical heart
valves, which require an INR between 2.5 and 3.5. INRs outside of this range are strongly
associated with an increased risk of major bleeding, thromboembolic events, and even death [3].
Laboratory monitoring of warfarin therapy, known as usual care, includes repeated venous
punctures to obtain INR results and subsequent dose adjustments by the health care provider [4].
Using conventional measures, frequency of INR monitoring is problematic in ambulatory
care. A research study showed that gaps in monitoring during warfarin therapy are associated
with poor anticoagulation control and adverse events [5]. The data related gaps to non-adherence
with INR monitoring and identified patient-level predictors, which included poverty, driving
distance, dementia, depression, and nonwhite race. Another study evaluated patient nonadherence to standard INR testing and found that the rate of thromboembolic events was higher in
the non-adherent group compared to the adherent group [6]. Non-adherence to INR monitoring is
a common and significant barrier to proper anticoagulation control.
The option of patient self-testing (PST) using a point-of-care (POC) device has
eliminated some of these barriers by enabling patients to test their INR levels at home via a
fingerstick blood sample, compared to outpatient visits to a laboratory or clinic. The POC device
communicates the INR result to the patient’s provider wirelessly, through a secured website, and
the provider adjusts the patient’s warfarin dose accordingly. Another option of patient self-
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management (PSM) is available, in which patients are trained to self-test and interpret the INR
result for dose adjustment.
Systematic reviews have shown PST/PSM to be superior to usual care with fewer
bleeding events and thromboembolic events, as well as reduced overall mortality [7-11].
Therefore, evidence-based clinical practice guidelines recommend PST/PSM to all suitable
patients receiving oral anticoagulation therapy [3, 12]. In this study, PST alone was implemented
and its effects analyzed.
Methods
Scope of the Problem
In January 2010, the clinical problem of non-therapeutic INRs in patients receiving
warfarin therapy was identified at a private practice setting in the southwest region of the United
States. The scope of the problem was appreciated after collecting INR results from contracted
laboratories over a 15-month period and calculating the average INR per quarter, or every three
months. Infrequent and inconsistent INR testing was the main factor contributing to nontherapeutic levels. Therefore, PST was proposed as a solution to the problem.
Patient Recruitment
The practice setting’s providers offered PST to patients if they met the following
inclusion criteria: indication for long-term warfarin therapy, such as chronic atrial fibrillation,
mechanical heart valve, and/or history of deep vein thrombosis; taking warfarin for at least 6
months; and willingness to participate in PST. Exclusion criteria included inability to perform the
test, due to factors such as poor coordination with hand tremor or poor visual acuity, and denial of
health insurance coverage for the device and PST-related billing expenses.
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Training
Providers referred eligible patients to the practice setting’s nurse practitioner who
provided hands-on device training during a 45- minute consultation appointment. At the end of
the appointment, the nurse practitioner assessed the patient’s competency via a return
demonstration. At the conclusion of the visit, the nurse practitioner provided the patient with a
meter reference manual as well as contact information if questions or problems occurred.
Online System
Once the POC device was received, all participating patients were instructed to test their
INR level at least once a week for the first month, or until therapeutic, and biweekly thereafter.
INR results were communicated to the provider via fax, phone call, and wirelessly through a
secured online system. If the result was above or below the prescribed therapeutic range, the
online system alerted the provider via phone call, requesting the provider to contact the patient
within 24 hours for warfarin dose adjustment. Provider telephone support was available to the
patients at all times.
Patients and providers were able to access the online system to view INR results. The
system also stored patient information such as demographics, indication for therapy, insurance
carrier information, provider, and past INR results. Information was only available to patients and
providers through a password-protected website.
Data Collection
Patient data were collected and analyzed from January 2010 to September 2014. Patient
data, including age, gender, indication for warfarin therapy, INR results, provider, and insurance
carrier, were collected from electronic medical records. Regardless of each patient’s start date,
INR results were collected for at least six months before and after PST implementation. Using
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Microsoft excel, INR results were organized by pre and post-PST implementation and the
averages were calculated every three months (quarterly) for data concision. INR averages were
analyzed using QI Macros software and X-bar-S control charts were created.
Results
Of the 36 patients recruited for this project from January 2010 to September 2014, eight
patients were excluded due to PST noncompliance, no longer being patients of the practice, or
death. A total of twenty-eight patients remained and were included in the analysis.
Table 1 Descriptive analysis

Group

# of
observations

Mean

Min

Max

Males

28

0.54

0.00

1.00

Age

28

71.80

26.84

91.31

Lab INR measurements

25

8.96

1.00

33.00

Meter INR measurements

28

87.93

7.00

228.00

Table 1 provides descriptive information about the sample used in the analysis. Males
made up 54% of the patients, and the average age of patients was 72 years (range 27 to 91 years).
In laboratory monitoring, 25 out of 28 patients had their INRs measured an average of 9 times
before receiving the meter for PST monitoring. During meter monitoring, all 28 patients
measured their INRs 88 times, on average, which is significantly greater than laboratory
monitoring frequency (p<0.001). Overall, PST increased the frequency of INR monitoring.
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S Control Chart Displaying Process Control for Laboratory Versus Metered INR
Fig. 1 X-bar-S
Monitoring
S control chart plots the process mean and process standard deviation for
The X-bar-S
patients to help determine the stability of INR measurements over time. The X
X-bar
bar-S control chart
is reported in Figure 1 and serves as an indicator of whether PST provided an improved and
consistent process over time compared to usual care. The dashed vertical line represents the point
at which PST was implemented and metered monitoring began, separating the laboratory INR
measurements from the metered INR measurements. In Figure 1, time (represented by the x-axis)
x
is partitioned into quarters with an “L” preceding the quarter number if data were collected when
patients were monitoring their INRs in a laboratory setting or an “M” preceding the quarter
number if data were collected
lected using metered monitoring to measure their INRs. The mean of
INRs is represented by the middle turquoise line, which shows an INR mean measurement of
approximately 2.5 in laboratory monitoring as compared with an INR mean measurement of
approximately 2.4 in metered monitoring. The upper and lower control limits are calculated as
three standard deviations above and below the mean, respectively. These limits are represented by
two red lines indicating an upper limit of 3.4 and a lower limit of 1.6 in la
laboratory
boratory monitoring as
compared with an upper limit of 2.8 and a lower limit of 2.1 in metered monitoring. The
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narrowing of control limits towards the therapeutic range over time (from laboratory monitoring
to metered monitoring) indicates that metered mon
monitoring
itoring is associated with greater control of
patients’ INR measurements within a desirable range. In comparison, laboratory monitoring has a
larger spread between its upper and lower control limits with variable results, suggesting a poorly
controlled process.
cess. In sum, average INRs in PST using metered monitoring are better controlled
than in usual care using laboratory monitoring. Overall, Figure 1 shows that metered monitoring
is associated with a more stable process as compared with laboratory monitoring,
monitoring with resulting
INR measurements occurring within a more desirable range.

Fig. 2 X-bar-S
S Control Chart Displaying Process Consistency of Laboratory Versus Metered INR
Monitoring
Figure 2 depicts the relative consistency of INR results by comparing the standard
s
deviations of laboratory data with those for metered monitoring. In the laboratory monitoring
phase, represented by quarters L1 to L5, there is more variation as seen by the larger upper and
lower controls limits as compared with the metered monito
monitoring
ring phase, which is represented by
quarters M1 to M17. After PST implementation, depicted by the dashed line, there is less
variation in the metered monitoring phase as indicated by the narrower upper and lower control
limits. The red points indicate stat
statistical
istical significance, which are seen immediately in quarters M1
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and M2. The trend of red points seen in quarters M6 to M12, indicates consistent and statistically
significant INR results. Although consistency slips in M3 to M5 and again after M13, metered
monitoring still provides dramatically more consistent INR results compared to the INR results
collected during laboratory monitoring.
Discussion
The results of this analysis provide insight to the quality of INR control in patients who
self-test, as well as the clinical efficacy of warfarin therapy. Additionally, the data from the
analysis allows a comparison of the quality of INR control between PST and usual care.
Since major adverse events and death could not be attributed to a confirmable cause in
the data, no analysis on the rate of major thromboembolic or bleeding events could be completed.
Thus, it is not possible to compare the rate of events in this data to the rate of newer oral
anticoagulants reported in studies. Furthermore, this analysis is based on data collected in clinical
practice, not in the controlled setting of a randomized controlled trial.
The mean frequency of INR testing was higher in PST using metered monitoring (88
times) than in usual care using laboratory monitoring (9 times). Testing frequency is strongly
correlated with INR control. Therefore, PST was found to be more efficient in maintaining INR
control and potentially reducing major adverse and fatal events, compared to usual care.
Moreover, the frequency of critical INR values is an important indicator of the effectiveness of
warfarin therapy. Critical INR values are defined as those below 1.5, carrying a major risk of a
thromboembolic event, and those above 5.0, carrying a major risk for a bleeding event [13, 14].
In Figure 1, the frequency of near-critical values is observed in the laboratory (usual care) data set
with the lower control limit of 1.6. There are no critical values seen in the metered (PST) data set
as the lower and upper control limits are within therapeutic range, 2.1 and 2.8, respectively. This
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suggests that PST is able to achieve tighter INR control within the defined therapeutic range of
2.0 to 3.0.
Conclusion
Overall, this project showed that PST was clinically more effective in INR monitoring
than usual care in our internal medicine practice. PST achieved tight INR control within
therapeutic range, improved therapeutic efficacy of warfarin, and enhanced treatment safety for
patients. Thus, PST should be offered and recommended as a vital element of INR monitoring of
long-term warfarin therapy.
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EFFECTIVENESS OF INR PATIENT SELF-TESTING: ADULTS ON WARFARIN
THERAPY IN INTERNAL MEDICINE
PURPOSE:
To compare the clinical effectiveness of INR patient self-testing in adults on warfarin therapy
versus usual care in an internal medicine practice.
BACKGROUND:
Warfarin is the most commonly prescribed oral anticoagulant for the prevention and treatment of
venous thromboembolism. Due to its narrow therapeutic index, warfarin requires close
monitoring of the international normalized ratio (INR) to ensure proper anticoagulation control
and safety. INRs outside of this range are strongly associated with an increased risk of major
bleeding, thromboembolic events and even death. Patient self-testing (PST) using a point-of-care
device allows patients to monitor their INR results from home. Evidence shows that PST
improves the clinical outcomes of warfarin therapy compared to usual care, which includes
laboratory INR monitoring.
METHODS:
Included competent and motivated adult patients with AF and/or DVT taking warfarin therapy for
at least 6 months. Excluded those unable to self-test or denied health insurance coverage for PSTrelated expenses. The clinic Nurse Practitioner provided hands-on meter training and set-up to
eligible patients. Competency and willingness to participate were assessed. Age, gender,
insurance carrier, provider, indication for warfarin therapy and INR results were collected from
January 2010 to September 2014. Quarterly INR averages (every 3 months) were calculated for
data concision using Microsoft Excel. Control charts were created using QI Macros to compare
laboratory INR data (usual care) to meter INR data (PST).
OUTCOMES:
In laboratory (usual care) monitoring, control limits are wide and INR results are variable, no
statistically significant INR averages resulted. In meter (PST) monitoring, control limits are
narrow and INR results are tightly controlled, resulting in statistically significant INR averages.
CONCLUSIONS:
Compared to usual care, PST resulted in tighter control of patients’ INR measurements within a
desirable range. PST provides a consistent process as well as a higher frequency of INR testing.
As recommended by evidence-based practice guidelines, PST should be offered to suitable
patients.

16

Poster

19

Stakeholders’ Powerpoint

.

20

21

